REDFILED (Page 16)

ArcelorMittal's Kryvyi Rih works is one of Ukraine's largest integrated steel plants.

MT

ARCELORMITTAL Halts Ukraine Steel Output After Second Missile Strike

A ballistic missile hit ArcelorMittal Kryvyi Rih on Saturday, killing two contractors and halting primary steel production with no repair timeline yet.

Ivonescimab is being studied as a first-line treatment for advanced non-small cell lung cancer.

SMMT

SUMMIT Partner Akeso Reports 8.2-Month Survival Edge Over Keytruda

Ivonescimab cut the risk of death 27% versus pembrolizumab in Akeso's Chinese Phase III HARMONi-2 trial, with median overall survival of 30.8 months.

Gotistobart is being developed for patients with squamous non-small cell lung cancer.

BNTX

BIONTECH Says Gotistobart Nearly Doubled Survival in Lung Cancer Trial

BioNTech and partner OncoC4 report first median overall survival data from stage 1 of the Phase 3 PRESERVE-003 trial in squamous NSCLC.

UPXI

UPEXI Cuts BitGo Loan Rate to 7.5%, Sees $2M Annual Savings

The Solana treasury company amended its BitGo Prime credit facility, lowering interest from 11.5% to 7.5% and reducing required collateral to 200%.

Anthony Hayes, chief executive of Dominari Holdings.

DOMH

DOMINARI Holdings CEO and President Buy $418K in Shares

Anthony Hayes and Kyle Wool each bought 100,000 Dominari shares on the open market over two days, a combined outlay of about $418,380.

Recovered copper and aluminum are among the material streams targeted at Project Headwaters.

AQMS

AQUA METALS Signs $105M Copper and Aluminum Offtake LOI for Headwaters

Non-binding five-year letter of intent covers up to all saleable copper and aluminum from the planned Midwest recycling plant, worth more than $105 million.

Definium is developing an orally disintegrating lysergide tablet for generalized anxiety disorder.

DFTX

DEFINIUM Posts Positive Phase 3 Panorama Data for LSD-Based Anxiety Drug

DT120 ODT cut Hamilton Anxiety scores 5.1 points more than placebo at Week 12, clearing the way for a pre-NDA meeting in 4Q 2026.

AstraZeneca is testing its oral SERD Etcamah across advanced and early breast cancer settings.

AZN

ASTRAZENECA Breast Cancer Trial SERENA-4 Misses Primary Endpoint

AstraZeneca's oral SERD Etcamah plus palbociclib failed to significantly improve progression-free survival in first-line advanced ER-positive breast cancer.

American Battery Technology operates a commercial-scale lithium-ion battery recycling plant in Nevada.

ABAT

AMERICAN BATTERY TECHNOLOGY Lifts FY26 Revenue 407% to $21.7 Million

The Reno-based recycler posted a gross loss of $3.1 million but turned adjusted gross profit positive at $1.7 million and ended the year debt-free with $49.5 million in cash.

Corbus is developing CRB-913 as an oral, non-incretin treatment for obesity.

CRBP

CORBUS Oral Obesity Pill CRB-913 Shows 5% Weight Loss in Phase 1b

Corbus reported statistically significant weight loss at all three doses of its oral CB1 inverse agonist, with a Phase 2 study planned for the first half of 2027.

Larry Ellison, executive chair and chief technology officer of Oracle.

ORCL

ORACLE Says Larry Ellison Has Cancelled His Stock Sale Plan

Oracle's executive chairman scrapped a 10b5-1 trading plan without selling any shares and says he has no other plans to sell Oracle stock.

Pham Nhat Quan Anh takes over as chief executive of VinFast.

VFS

VINFAST Names Pham Nhat Quan Anh CEO, Succeeding Founder Vuong

The Vietnamese EV maker appointed its chairman as chief executive effective September 12, with billionaire founder Pham Nhat Vuong staying on the board.

Latest